1160697-64-2Relevant academic research and scientific papers
A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: Development of a synthetically accessible protein kinase C activator with bryostatin-like activity
Nakagawa, Yu,Yanagita, Ryo C.,Hamada, Naoko,Murakami, Akira,Takahashi, Hideyuki,et al.
supporting information; experimental part, p. 7573 - 7579 (2009/10/17)
Protein kinase C (PKC) is widely recognized as a therapeutic target in intractable diseases such as cancer, Alzheimer's disease (AD), and acquired immune deficiency syndrome (AIDS). While inhibition of PKC is a general therapeutic strategy for the treatme
